nVerses Capital’s Nu Skin NUS Stock Holding History

nVerses Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,300	Closed	-$24.3K	–	589
2024 Q3	$24.3K	Sell	3,300 -3,800	-54%	-$35.5K	0.01%	778
2024 Q2	$74.8K	Buy	+7,100	New	+$90K	0.04%	502

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

nVerses Capital's NUS Position: Q4 2024 in Review

nVerses Capital sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 3,300 shares — an estimated $24.3K sold.

nVerses Capital first reported a position in NUS in Q2 2024 and held it in 2 quarters. The position peaked at $74.8K in Q2 2024. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

nVerses Capital reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 3,300 Nu Skin shares in Q4 2024, an estimated $24.3K.
nVerses Capital first reported a position in Nu Skin in Q2 2024 and held it in 2 quarters.
nVerses Capital's Nu Skin position peaked at $74.8K in Q2 2024.
200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.